Volume 28

AIDS

Volume 28
1

Improving early childhood development outcomes for children affected by HIV and AIDS

Year:
2014
Language:
english
File:
PDF, 128 KB
english, 2014
16

Persistent HIV infection in newborns

Year:
2014
Language:
english
File:
PDF, 139 KB
english, 2014
18

A closer look at hepatitis C clearance in HIV controllers

Year:
2014
Language:
english
File:
PDF, 285 KB
english, 2014
24

Epicardial adipose tissue and atherogenesis

Year:
2014
Language:
english
File:
PDF, 144 KB
english, 2014
26

Antiretroviral drugs for prevention of mother-to-child transmission

Year:
2014
Language:
english
File:
PDF, 342 KB
english, 2014
28

How to identify HIV-infected individuals at risk for atherosclerotic events?

Year:
2014
Language:
english
File:
PDF, 168 KB
english, 2014
29

Research on oral pre-exposure prophylaxis in sub-Saharan Africa is an example of biomedical tunnel vision

Year:
2014
Language:
english
File:
PDF, 304 KB
english, 2014
30

Efavirenz dose reduction in HIV-infected patients

Year:
2014
Language:
english
File:
PDF, 158 KB
english, 2014
41

Genetic variation in Trex1 affects HIV-1 disease progression

Year:
2014
Language:
english
File:
PDF, 248 KB
english, 2014
43

Early childhood development

Year:
2014
Language:
english
File:
PDF, 138 KB
english, 2014
44

Osteoporosis and fractures in HIV/hepatitis C virus coinfection

Year:
2014
Language:
english
File:
PDF, 496 KB
english, 2014
51

Diversity of HIV/AIDS epidemic in China

Year:
2014
Language:
english
File:
PDF, 543 KB
english, 2014
52

The case of adherence in the youth

Year:
2014
Language:
english
File:
PDF, 156 KB
english, 2014
53

The vaginal microbiota and susceptibility to HIV

Year:
2014
Language:
english
File:
PDF, 389 KB
english, 2014
56

Risk of non-AIDS-defining cancers among HIV-1-infected individuals in France between 1997 and 2009

Year:
2014
Language:
english
File:
PDF, 442 KB
english, 2014
60

Preconception antiretroviral therapy and birth defects

Year:
2014
Language:
english
File:
PDF, 207 KB
english, 2014
61

Maternal HIV disclosure to young HIV-uninfected children

Year:
2014
Language:
english
File:
PDF, 314 KB
english, 2014
71

Moxifloxacin for Buruli ulcer/HIV-coinfected patients

Year:
2014
Language:
english
File:
PDF, 160 KB
english, 2014
76

HIV estimates at second subnational level from national population-based surveys

Year:
2014
Language:
english
File:
PDF, 717 KB
english, 2014
79

Cash plus care

Year:
2014
Language:
english
File:
PDF, 341 KB
english, 2014
80

Evidence of impact

Year:
2014
Language:
english
File:
PDF, 314 KB
english, 2014
90

Increasing trends in HIV prevalence among people aged 50 years and older

Year:
2014
Language:
english
File:
PDF, 486 KB
english, 2014
120

PEPFAR

Year:
2014
Language:
english
File:
PDF, 162 KB
english, 2014
123

Potential impact of statins on cancer incidence in HIV-infected patients

Year:
2014
Language:
english
File:
PDF, 171 KB
english, 2014
124

Adherence to antiretroviral therapy in adolescents living with HIV

Year:
2014
Language:
english
File:
PDF, 524 KB
english, 2014
153

Redefining the HIV epidemic in Nigeria

Year:
2014
Language:
english
File:
PDF, 397 KB
english, 2014
154

Decline in locomotor functions over time in HIV-infected patients

Year:
2014
Language:
english
File:
PDF, 147 KB
english, 2014
159

Estimating future trends in paediatric HIV

Year:
2014
Language:
english
File:
PDF, 378 KB
english, 2014
164

Should we not pay attention to what women tell us when they vote with their feet?

Year:
2014
Language:
english
File:
PDF, 200 KB
english, 2014
165

Screening for anal cancer precursors

Year:
2014
Language:
english
File:
PDF, 276 KB
english, 2014
172

Do ask, do tell

Year:
2014
Language:
english
File:
PDF, 188 KB
english, 2014
174

Practical guidance for nonoccupational postexposure prophylaxis to prevent HIV infection

Year:
2014
Language:
english
File:
PDF, 298 KB
english, 2014
180

The challenge of paediatric efavirenz dosing

Year:
2014
Language:
english
File:
PDF, 177 KB
english, 2014
181

The transmembrane proteins contribute to immunodeficiencies induced by HIV-1 and other retroviruses

Year:
2014
Language:
english
File:
PDF, 375 KB
english, 2014
182

Children born into families affected by HIV

Year:
2014
Language:
english
File:
PDF, 192 KB
english, 2014
183

Isolated hepatitis B surface antigenemia in an HIV-1-positive individual

Year:
2014
Language:
english
File:
PDF, 276 KB
english, 2014
200

Poverty matters

Year:
2014
Language:
english
File:
PDF, 254 KB
english, 2014
203

Texting improves testing

Year:
2014
Language:
english
File:
PDF, 274 KB
english, 2014
209

From patient to person

Year:
2014
Language:
english
File:
PDF, 339 KB
english, 2014
213

Triple secondary neoplasms

Year:
2014
Language:
english
File:
PDF, 303 KB
english, 2014
223

Social and ethical implications of HIV cure research

Year:
2014
Language:
english
File:
PDF, 197 KB
english, 2014
229

The protective effect of HIV-2 infection

Year:
2014
Language:
english
File:
PDF, 184 KB
english, 2014
233

Malignancies in HIV/AIDS

Year:
2014
Language:
english
File:
PDF, 663 KB
english, 2014
239

Antiretroviral reduction

Year:
2014
Language:
english
File:
PDF, 185 KB
english, 2014
246

Acute HIV-1 infection in sub-Saharan Africa

Year:
2014
Language:
english
File:
PDF, 168 KB
english, 2014
251

Estimating per-act HIV transmission risk

Year:
2014
Language:
english
File:
PDF, 362 KB
english, 2014
258

Some current issues in the design of HIV noninferiority trials

Year:
2014
Language:
english
File:
PDF, 470 KB
english, 2014
264

Incorporating incidence information within the UNAIDS Estimation and Projection Package framework

Year:
2014
Language:
english
File:
PDF, 652 KB
english, 2014
265

Examining non-AIDS mortality among people who inject drugs

Year:
2014
Language:
english
File:
PDF, 390 KB
english, 2014
266

Antiretroviral nanoparticles

Year:
2014
Language:
english
File:
PDF, 156 KB
english, 2014
271

Better economic tools for evaluating health and development investments

Year:
2014
Language:
english
File:
PDF, 178 KB
english, 2014
272

Dropout and re-enrollment

Year:
2014
Language:
english
File:
PDF, 330 KB
english, 2014
276

On the speculations about the causes of increased condom use in Africa

Year:
2014
Language:
english
File:
PDF, 1.23 MB
english, 2014
278

Reactivation of hepatitis B virus infection associated with maraviroc use in an HIV-infected patient

Year:
2014
Language:
english
File:
PDF, 2.08 MB
english, 2014
279

Commentary

Year:
2014
Language:
english
File:
PDF, 72 KB
english, 2014
282

Abacavir-induced liver toxicity in an HIV-infected patient

Year:
2014
Language:
english
File:
PDF, 246 KB
english, 2014
290

HIV infection and the fronto–striatal system

Year:
2014
Language:
english
File:
PDF, 203 KB
english, 2014
301

Paclitaxel for relapsed or recurrent HIV-associated pediatric Kaposiʼs sarcoma

Year:
2014
Language:
english
File:
PDF, 1.29 MB
english, 2014
307

Commentary

Year:
2014
Language:
english
File:
PDF, 199 KB
english, 2014
310

Moorenʼs ulcer of the cornea after immune reconstitution

Year:
2014
Language:
english
File:
PDF, 1.35 MB
english, 2014
317

Anal microbiota profiles in HIV-positive and HIV-negative MSM

Year:
2014
Language:
english
File:
PDF, 539 KB
english, 2014
324

Recent cancer trends in HIV-infected individuals in the United States

Year:
2014
Language:
english
File:
PDF, 139 KB
english, 2014
327

Antiretroviral therapy increases thymic output in children with HIV

Year:
2014
Language:
english
File:
PDF, 564 KB
english, 2014
328

Azathioprine can be safely used in HIV-infected individuals

Year:
2014
Language:
english
File:
PDF, 1.31 MB
english, 2014
330

Does pregnancy affect the pharmacokinetics of efavirenz?

Year:
2014
Language:
english
File:
PDF, 304 KB
english, 2014
331

Tumor growth inhibition by ritonavir

Year:
2014
Language:
english
File:
PDF, 7.25 MB
english, 2014
342

Beneficial impact of antiretroviral therapy on non-AIDS mortality

Year:
2014
Language:
english
File:
PDF, 154 KB
english, 2014
347

Commentary

Year:
2014
Language:
english
File:
PDF, 194 KB
english, 2014
348

Is preexposure prophylaxis ready for prime time use in HIV prevention research?

Year:
2014
Language:
english
File:
PDF, 171 KB
english, 2014
349

Commentary

Year:
2014
Language:
english
File:
PDF, 178 KB
english, 2014
360

Racial disparity in HIV incidence in MSM in the United States

Year:
2014
Language:
english
File:
PDF, 174 KB
english, 2014
367

Biomarkers for sexual behaviour change

Year:
2014
Language:
english
File:
PDF, 285 KB
english, 2014
374

Homage to Joep Lange

Year:
2014
Language:
english
File:
PDF, 129 KB
english, 2014
377

Reversible bone lesions induced by tenofovir disoproxil fumarate

Year:
2014
Language:
english
File:
PDF, 1.31 MB
english, 2014
381

Relative time to pregnancy among HIV-infected and uninfected women in the Womenʼs Interagency HIV study, 2002–2009

Year:
2014
Language:
english
File:
PDF, 74 KB
english, 2014
399

Financing structural interventions

Year:
2014
Language:
english
File:
PDF, 309 KB
english, 2014
401

The increasing genetic diversity of HIV-1 in the UK, 2002–2010

Year:
2014
Language:
english
File:
PDF, 1.21 MB
english, 2014
414

Looking upstream to prevent HIV transmission

Year:
2014
Language:
english
File:
PDF, 346 KB
english, 2014
419

Will loss of your mucosa-associated invariant T cells weaken your HAART?

Year:
2014
File:
PDF, 48 KB
2014
425

Commentary

Year:
2014
Language:
english
File:
PDF, 175 KB
english, 2014
427

Response to using incidence assays within the context of the recent infections testing algorithm

Year:
2014
Language:
english
File:
PDF, 355 KB
english, 2014
429

Estimating HIV incidence from case-report data

Year:
2014
Language:
english
File:
PDF, 494 KB
english, 2014